A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer

The evolving role of immunotherapy in prostate cancer

(2012) W. R. Gerritsen   ANNALS OF ONCOLOGY

Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy

(2012) Nicolò Rigamonti et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Treatment Decisions for Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel Chemotherapy: The Role of Cabazitaxel in the Continuum of Care

(2012) Axel Heidenreich et al.   EUROPEAN UROLOGY

Novel Agents and Approaches for Advanced Renal Cell Carcinoma

(2012) Robert Figlin et al.   JOURNAL OF UROLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

(2011) Robert E. Hunger et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Multiple Vaccinations

(2011) Sarah E. Church et al.   CANCER JOURNAL

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

(2011) P. F. Brunsvig et al.   CLINICAL CANCER RESEARCH

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

(2010) Susanne M Rittig et al.   MOLECULAR THERAPY

Key concepts in immunology

(2010) Muriel Moser et al.   VACCINE

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

The Immunogenicity of the hTERT540-548 Peptide in Cancer

(2008) L. Wenandy et al.   CLINICAL CANCER RESEARCH

Telomerase as a universal tumor antigen for cancer vaccines

(2008) Gregory L Beatty et al.   Expert Review of Vaccines

Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma

(2008) Annika Berntsen et al.   JOURNAL OF IMMUNOTHERAPY